is semaglutide on the fda shortage list Ozempic and Wegovy removed from FDA's drug FDA: Shortage of popular weight-loss,

The platform pitches itself as a price leader in the compounded GLP-1 space, leaning on affordability and speed as its core differentiators while also marketing a comprehensive support model that includes unlimited physician messaging and progress tracking through its app

Historically, GLP-1-class compounds produce somewhat lower percent weight loss in diabetic populations than in non-diabetic ones

Unlike stimulants that artificially elevate energy through increased catecholamine activity, any energy improvements with tirzepatide are generally secondary to weight loss and improved metabolic health

Its about creating specific periods for eating and fasting, which can bring several health benefits